American Century Companies trimmed its stake in Regeneron Pharmaceuticals by 4.2% during Q4, selling nearly 31,000 shares and ...
Regeneron Pharmaceuticals Inc. closed 47.64% short of its 52-week high of $1,211.20, which the company reached on August 27th.
Advisors Asset Management Inc. trimmed its stake in Regeneron Pharmaceuticals by 7.9%, selling 443 shares in the fourth ...
Reported positive data updates from its ongoing Phase 2a trial of lead program IMM-1-104, including encouraging responses in combination with chemotherapy in first-line pancreatic cancer - - Announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback